Exposure to SIV in utero results in reduced viral loads and altered responsiveness to postnatal challenge

Science Translational Medicine

Volumn 7, Issue 300, 2015, Pages

  Baker, Chris A R ^a,b   Swainson, Louise ^b   Lin, Din L ^b   Wong, Samson ^b   Hartigan O'Connor, Dennis J ^b,c,d   Lifson, Jeffrey D ^e   Tarantal, Alice F ^c,d   McCune, Joseph M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 2; KI 67 ANTIGEN; PROGRAMMED DEATH 1 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; VIRUS DNA; VIRUS RNA; EPITOPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CD4 CD8 RATIO; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FETUS; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INTRAUTERINE INFECTION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; TH17 CELL; VIRUS LOAD; VIRUS REPLICATION; ANIMAL; BLOOD; CELL COUNT; IMMUNOLOGY; METABOLISM; NEWBORN; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; SIMIAN IMMUNODEFICIENCY VIRUS; VIROLOGY;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; CELL COUNT; EPITOPES; FEMALE; IMMUNE TOLERANCE; KI-67 ANTIGEN; MACACA MULATTA; RNA, VIRAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TH17 CELLS; VIRAL LOAD;

EID: 84939452170     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aac5547     Document Type: Article

References (66)

1. A. S. Fauci, M. A. Marovich, C. W. Dieffenbach, E. Hunter, S. P. Buchbinder, Immunology. Immune activation with HIV vaccines. Science 344, 49-51 (2014).
2. J. M. McCune, The dynamics of CD4+ T-cell depletion in HIV disease. Nature 410, 974-979 (2001).
3. A. A. Okoye, L. J. Picker, CD4+ T-cell depletion in HIV infection: Mechanisms of immunological failure. Immunol. Rev. 254, 54-64 (2013).
4. B. Autran, B. Descours, C. Bacchus, Immune control of HIV-1 reservoirs. Curr. Opin. HIV AIDS 8, 204-210 (2013).
5. N. R. Klatt, N. Chomont, D. C. Douek, S. G. Deeks, Immune activation and HIV persistence: Implications for curative approaches to HIV infection. Immunol. Rev. 254, 326-342 (2013).
6. A. Chahroudi, S. E. Bosinger, T. H. Vanderford, M. Paiardini, G. Silvestri, Natural SIV hosts: Showing AIDS the door. Science 335, 1188-1193 (2012).
7. D. Favre, S. Lederer, B. Kanwar, Z. M. Ma, S. Proll, Z. Kasakow, J. Mold, L. Swainson, J. D. Barbour, C. R. Baskin, R. Palermo, I. Pandrea, C. J. Miller, M. G. Katze, J. M. McCune, Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLOS Pathog. 5, e1000295 (2009).
8. S. Lederer, D. Favre, K. A. Walters, S. Proll, B. Kanwar, Z. Kasakow, C. R. Baskin, R. Palermo, J. M. McCune, M. G. Katze, Transcriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalization. PLOS Pathog. 5, e1000296 (2009).
9. I. V. Pandrea, R. Gautam, R. M. Ribeiro, J. M. Brenchley, I. F. Butler, M. Pattison, T. Rasmussen, P. A. Marx, G. Silvestri, A. A. Lackner, A. S. Perelson, D. C. Douek, R. S. Veazey, C. Apetrei, Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence. J. Immunol. 179, 3035-3046 (2007).
10. G. Silvestri, AIDS pathogenesis: A tale of two monkeys. J. Med. Primatol. 37 (Suppl. 2), 6-12 (2008).
11. P. H. Naylor, J. W. Hadden, T cell targeted immune enhancement yields effective T cell adjuvants. Int. Immunopharmacol. 3, 1205-1215 (2003).
12. P. H. Lambert, M. Liu, C. A. Siegrist, Can successful vaccines teach us how to induce efficient protective immune responses? Nat. Med. 11, S54-S62 (2005).
13. S. G. Hansen, C. Vieville, N. Whizin, L. Coyne-Johnson, D. C. Siess, D. D. Drummond, A. W. Legasse, M. K. Axthelm, K. Oswald, C. M. Trubey, M. Piatak, J. D. Lifson, J. A. Nelson, M. A. Jarvis, L. J. Picker, Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat. Med. 15, 293-299 (2009).
14. T. W. Chun, D. Engel, M. M. Berrey, T. Shea, L. Corey, A. S. Fauci, Early establishment of a pool of latently infected, resting CD4+ T cells during primary HIV-1 infection. Proc. Natl. Acad. Sci. U.S.A. 95, 8869-8873 (1998).
15. J. J. Mattapallil, D. C. Douek, B. Hill, Y. Nishimura, M. Martin, M. Roederer, Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434, 1093-1097 (2005).
16. D. Persaud, H. Gay, C. Ziemniak, Y. H. Chen, M. Piatak, T. W. Chun, M. Strain, D. Richman, K. Luzuriaga, Absence of detectable HIV-1 viremia after treatment cessation in an infant. N. Engl. J. Med. 369, 1828-1835 (2013).
17. A. Sáez-Cirión, C. Bacchus, L. Hocqueloux, V. Avettand-Fenoel, I. Girault, C. Lecuroux, V. Potard, P. Versmisse, A. Melard, T. Prazuck, B. Descours, J. Guergnon, J. P. Viard, F. Boufassa, O. Lambotte, C. Goujard, L.Meyer, D. Costagliola, A. Venet, G. Pancino, B. Autran, C. Rouzioux; ANRS VISCONTI Study Group, Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI study. PLOS Pathog. 9, e1003211 (2013).
18. N. Gupta, S. Culina, Y. Meslier, J. Dimitrov, C. Arnoult, S. Delignat, B. Gangadharan, M. Lecerf, S. Justesen, V. Gouilleux-Gruart, B. L. Salomon, D. W. Scott, S. V. Kaveri, R. Mallone, S. Lacroix-Desmazes, Regulation of immune responses to protein therapeutics by transplacental induction of T cell tolerance. Sci. Transl. Med. 7, 275ra21 (2015).
19. J. E. Mold, J. M. McCune, Immunological tolerance during fetal development: From mouse to man. Adv. Immunol. 115, 73-111 (2012).
20. R. Rachid, D. T. Umetsu, Immunological mechanisms for desensitization and tolerance in food allergy. Semin. Immunopathol. 34, 689-702 (2012).
21. M. H. Shamji, S. R. Durham, Mechanisms of immunotherapy to aeroallergens. Clin. Exp. Allergy 41, 1235-1246 (2011).
22. D. A. Lehman, C. Farquhar, Biological mechanisms of vertical human immunodeficiency virus (HIV-1) transmission. Rev. Med. Virol. 17, 381-403 (2007).
23. G. Scarlatti, Paediatric HIV infection. Lancet 348, 863-868 (1996).
24. J. E. Mold, S. Venkatasubrahmanyam, T. D. Burt, J. Michalsson, J. M. Rivera, S. A. Galkina, K. Weinberg, C. A. Stoddart, J. M. McCune, Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans. Science 330, 1695-1699 (2010).
25. J. E. Mold, J. Michalsson, T. D. Burt, M. O. Muench, K. P. Beckerman, M. P. Busch, T.-H. Lee, D. F. Nixon, J. M. McCune, Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 322, 1562-1565 (2008).
26. E. R. Krow-Lucal, C. C. Kim, T. D. Burt, J. M. McCune, Distinct functional programming of human fetal and adult monocytes. Blood 123, 1897-1904 (2014).
27. C. A. Batchelder, N. Duru, C. I. Lee, C. A. Baker, L. Swainson, J. M. McCune, A. F. Tarantal, Myeloid-Lymphoid ontogeny in the rhesus monkey (Macaca mulatta). Anat. Rec. 297, 1392-1406 (2014).
28. M. G. Otsyula, C. J. Miller, A. F. Tarantal,M. L. Marthas, T. P. Greene, J. R. Collins, K. K. van Rompay, M. B. McChesney, Fetal or neonatal infection with attenuated simian immunodeficiency virus results in protective immunity against oral challenge with pathogenic SIVmac251. Virology 222, 275-278 (1996).
29. R. J. Robb, K. E. Lineburg, R. D. Kuns, Y. A. Wilson, N. C. Raffelt, S. D. Olver, A. Varelias, K. A. Alexander, B. E. Teal, T. Sparwasser, G. J. Hammerling, K. A. Markey, M. Koyama, A. D. Clouston, C. R. Engwerda, G. R. Hill, K. P. MacDonald, Identification and expansion of highly suppressive CD8+Foxp3+ regulatory T cells after experimental allogeneic bone marrow transplantation. Blood 119, 5898-5908 (2012).
30. C. L. Day, D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, Z. Mncube, J. Duraiswamy, B. Zhu, Q. Eichbaum, M. Altfeld, E. J. Wherry, H. M. Coovadia, P. J. Goulder, P. Klenerman, R. Ahmed, G. J. Freeman, B. D. Walker, PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350-354 (2006).
31. A. Sakhdari, S. Mujib, B. Vali, F. Y. Yue, S. MacParland, K. Clayton, R. B. Jones, J. Liu, E. Y. Lee, E. Benko, C. Kovacs, J. Gommerman, R. Kaul, M. A. Ostrowski, Tim-3 negatively regulates cytotoxicity in exhausted CD8+ T cells in HIV infection. PLOS One 7, e40146 (2012).
32. J. Y. Zhang, Z. Zhang, X. Wang, J. L. Fu, J. Yao, Y. Jiao, L. Chen, H. Zhang, J. Wei, L. Jin, M. Shi, G. F. Gao, H. Wu, F. S. Wang, PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors. Blood 109, 4671-4678 (2007).
33. Y. Fukazawa, H. Park, M. J. Cameron, F. Lefebvre, R. Lum, N. Coombes, E. Mahyari, S. I. Hagen, J. Y. Bae, M. D. Reyes III, T. Swanson, A. W. Legasse, A. Sylwester, S. G. Hansen, A. T. Smith, P. Stafova, R. Shoemaker, Y. Li, K. Oswald, M. K. Axthelm, A. McDermott, G. Ferrari, D. C. Montefiori, P. T. Edlefsen, M. Piatak Jr., J. D. Lifson, R. P. Skaly, L. J. Picker, Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines. Nat. Med. 18, 1673-1681 (2012).
34. W. Lu, S. Chen, C. Lai, W. Guo, L. Fu, J. M. Andrieu, Induction of CD8+ regulatory T cells protects macaques against SIV challenge. Cell Rep. 2, 1736-1746 (2012).
35. S. F. Sieg, D. A. Bazdar, M. M. Lederman, Impaired TCR-mediated induction of Ki67 by naive CD4+ T cells is only occasionally corrected by exogenous IL-2 in HIV-1 infection. J. Immunol. 171, 5208-5214 (2003).
36. M. Tsurusawa, T. Fujimoto, Cell cycle progression and phenotypic modification of Ki67 antigen-negative G1- and G2-phase cells in phorbol ester-treated Molt-4 human leukemia cells. Cytometry 20, 146-153 (1995).
37. B. Knoechel, J. Lohr, S. Zhu, L. Wong, D. Hu, L. Ausubel, A. K. Abbas, Functional and molecular comparison of anergic and regulatory T lymphocytes. J. Immunol. 176, 6473-6483 (2006).
38. V. Cecchinato, G. Franchini, Th17 cells in pathogenic simian immunodeficiency virus infection of macaques. Curr. Opin. HIV AIDS 5, 141-145 (2010).
39. D. Favre, J. Mold, P. W. Hunt, B. Kanwar, P. Loke, L. Seu, J.D. Barbour, M.M. Lowe, A. Jayawardene, F. Aweeka, Y. Huang, D. C. Douek, J. M. Brenchley, J. N. Martin, F. M. Hecht, S. G. Deeks, J. M. McCune, Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci. Transl. Med. 2, 32ra36 (2010).
40. B. Kanwar, D. Favre, J. M. McCune, Th17 and regulatory T cells: Implications for AIDS pathogenesis. Curr. Opin. HIV AIDS 5, 151-157 (2010).
41. N. R. Klatt, J. D. Estes, X. Sun, A. M. Ortiz, J. S. Barber, L. D. Harris, B. Cervasi, L. K. Yokomizo, L. Pan, C. L. Vinton, B. Tabb, L. A. Canary, Q. Dang, V. M. Hirsch, G. Alter, Y. Belkaid, J. D. Lifson, G. Silvestri, J. D. Milner, M. Paiardini, E. K. Haddad, J. M. Brenchley, Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol. 5, 646-657 (2012).
42. R. K. Reeves, P. A. Rajakumar, T. I. Evans, M. Connole, J. Gillis, F. E. Wong, Y. V. Kuzmichev, A. Carville, R. P. Johnson, Gut inflammation and indoleamine deoxygenase inhibit IL-17 production and promote cytotoxic potential in NKp44+ mucosal NK cells during SIV infection. Blood 118, 3321-3330 (2011).
43. H. Xu, X. Wang, D. X. Liu, T. Moroney-Rasmussen, A. A. Lackner, R. S. Veazey, IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques. Mucosal Immunol. 5, 658-669 (2012).
44. D. J. Hartigan-O'Connor, K. Abel, K. K. Van Rompay, B. Kanwar, J. M. McCune, SIV replication in the infected rhesus macaque is limited by the size of the preexisting Th17 cell compartment. Sci. Transl. Med. 4, 136ra69 (2012).
45. P. Ancuta, P. Monteiro, R. P. Sekaly, Th17 lineage commitment and HIV-1 pathogenesis. Curr. Opin. HIV AIDS 5, 158-165 (2010).
46. A. Elhed, D. Unutmaz, Th17 cells and HIV infection. Curr. Opin. HIV AIDS 5, 146-150 (2010).
47. P. W. Hunt, Th17, gut, and HIV: Therapeutic implications. Curr. Opin. HIV AIDS 5, 189-193 (2010).
48. C. H. Kim, Migration and function of Th17 cells. Inflamm. Allergy Drug Targets 8, 221-228 (2009).
49. M. Paiardini, Th17 cells in natural SIV hosts. Curr. Opin. HIV AIDS 5, 166-172 (2010).
50. Y. S. Suh, K. S. Park, U. Sauermann, K. S. Kim, S. S. Ahn, M. Franz, R. Schulte, D. Wilfingseder, H. Stoiber, K. Uberla, G. Hunsmann, C. Stahl-Hennig, Y. C. Sung, Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase. Vaccine 26, 6690-6698 (2008).
51. N. Dauby, T. Goetghebuer, T. R. Kollmann, J. Levy, A. Marchant, Uninfected but not unaffected: Chronic maternal infections during pregnancy, fetal immunity, and susceptibility to postnatal infections. Lancet Infect. Dis. 12, 330-340 (2012).
52. I. Malhotra, P. L. Mungai, A. N. Wamachi, D. Tisch, J. M. Kioko, J. H. Ouma, E. Muchiri, J. W. Kazura, C. L. King, Prenatal T cell immunity to Wuchereria bancrofti and its effect on filarial immunity and infection susceptibility during childhood. J. Infect. Dis. 193, 1005-1013 (2006).
53. M. S. Mackroth, I. Malhotra, P. Mungai, D. Koech, E. Muchiri, C. L. King, Human cord blood CD4+CD25hi regulatory T cells suppress prenatally acquired T cell responses to Plasmodium falciparum antigens. J. Immunol. 186, 2780-2791 (2011).
54. L. Kuhn, S. Meddows-Taylor, G. Gray, C. Tiemessen, Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero. Clin. Infect. Dis. 34, 267-276 (2002).
55. K. C. Rich, J. N. Siegel, C. Jennings, R. J. Rydman, A. L. Landay, Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin. Diagn. Lab. Immunol. 4, 358-361 (1997).
56. F. A. Legrand, D. F. Nixon, C. P. Loo, E. Ono, J. M. Chapman, M. Miyamoto, R. S. Diaz, A. M. N. Santos, R. C. M. Succi, J. Abadi, M. G. Rosenberg, M. I. de Moraes-Pinto, E. G. Kallas, Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PLOS One 1, e102 (2006).
57. H. M. McClure, D. C. Anderson, P. N. Fultz, A. A. Ansari, T. Jehuda-Cohen, F. Villinger, S. A. Klumpp, W. Switzer, E. Lockwood, A. Brodie, Maternal transmission of SIVsmm in rhesus macaques. J. Med. Primatol. 20, 182-187 (1991).
58. I. Pandrea, N. F. Parrish, K. Raehtz, T. Gaufin, H. J. Barbian, D. Ma, J. Kristoff, R. Gautam, F. Zhong, G. S. Haret-Richter, A. Trichel, G. M. Shaw, B. H. Hahn, C. Apetrei, Mucosal simian immunodeficiency virus transmission in African green monkeys: Susceptibility to infection is proportional to target cell availability at mucosal sites. J. Virol. 86, 4158-4168 (2012).
59. P. W. Hunt, J. Brenchley, E. Sinclair, J. M. McCune, M. Roland, K. Page-Shafer, P. Hsue, B. Emu, M. Krone, H. Lampiris, D. Douek, J. N. Martin, S. G. Deeks, Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J. Infect. Dis. 197, 126-133 (2008).
60. H. Ipp, A. E. Zemlin, R. T. Erasmus, R. H. Glashoff, Role of inflammation in HIV-1 disease progression and prognosis. Crit. Rev. Clin. Lab. Sci. 51, 98-111 (2014).
61. C. Katlama, S. G. Deeks, B. Autran, J. Martinez-Picado, J. van Lunzen, C. Rouzioux, M. Miller, S. Vella, J. E. Schmitz, J. Ahlers, D. D. Richman, R. P. Sekaly, Barriers to a cure for HIV: New ways to target and eradicate HIV-1 reservoirs. Lancet 381, 2109-2117 (2013).
62. J. M. Andrieu, S. Chen, C. Lai, W. Guo, W. Lu, Mucosal SIV vaccines comprising inactivated virus particles and bacterial adjuvants induce CD8+ T-regulatory cells that suppress SIVpositive CD4+ T-cell activation and prevent SIV infection in the macaque model. Front. Immunol. 5, 297 (2014).
63. J. T. Loffredo, J. Maxwell, Y. Qi, C. E. Glidden, G. J. Borchardt, T. Soma, A. T. Bean, D. R. Beal, N. A. Wilson, W. M. Rehrauer, J. D. Lifson, M. Carrington, D. I. Watkins, Mamu-B∗08-positive macaques control simian immunodeficiency virus replication. J. Virol. 81, 8827-8832 (2007).
64. A. F. Tarantal, Ultrasound imaging in rhesus (Macaca mulatta) and long-tailed (Macaca fascicularis) macaques: Reproductive and research applications, in The Laboratory Primate (Elsevier Academic Press, San Diego, CA, 2005), chap. 20.
65. M. L.Marthas, R. A. Ramos, B. L. Lohman, K. K. Van Rompay, R. E. Unger, C. J. Miller, B. Banapour, N. C. Pedersen, P. A. Luciw, Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac. J. Virol. 67, 6047-6055 (1993).
66. S. G. Hansen, M. Piatak Jr., A. B. Ventura, C. M. Hughes, R. M. Gilbride, J. C. Ford, K. Oswald, R. Shoemaker, Y. Li, M. S. Lewis, A. N. Gilliam, G. Xu, N.Whizin, B. J. Burwitz, S. L. Planer, J. M. Turner, A. W. Legasse, M. K. Axthelm, J. A. Nelson, K. Frh, J. B. Sacha, J. D. Estes, B. F. Keele, P. T. Edlefsen, J. D. Lifson, L. J. Picker, Immune clearance of highly pathogenic SIV infection. Nature 502, 100-104 (2013).